semaglutide mash approval The FDA has approved Wegovy (semaglutide) as a treatment for metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program FDA Approves Semaglutide for MASH

Dee KC, Rueger DC, Andersen TT, Bizios R

You can learn more about LDN in my article Low-Dose Naltrexone: A Promising Drug for Hard-to-Treat Conditions and find a prescriber near you on the LDN Research Trust website

Creatine is a supplement shown to increase physical performance in short, high-intensity exercise, like sprinting and weight lifting

A documented case report published in a peer-reviewed medical journal described a patient whose antipsychotic medication levels rose after starting Semaglutide, a pattern researchers linked to slowed gastric emptying affecting how the antipsychotic was absorbed and processed

Studies show that people taking tirzepatide lose significantly more body weight, which may be especially helpful if youve hit a plateau on semaglutide